MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 206 filers reported holding MYRIAD GENETICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $640,179 | -30.8% | 39,936 | +0.0% | 0.00% | -100.0% |
Q2 2023 | $925,380 | -0.2% | 39,930 | -0.1% | 0.00% | 0.0% |
Q1 2023 | $926,947 | +318.3% | 39,971 | +161.4% | 0.00% | – |
Q4 2022 | $221,621 | -24.2% | 15,289 | -50.0% | 0.00% | – |
Q3 2022 | $292,292 | +5.1% | 30,580 | +100.2% | 0.00% | – |
Q2 2022 | $278,000 | -27.6% | 15,275 | -0.1% | 0.00% | – |
Q1 2022 | $384,000 | -9.0% | 15,286 | +0.1% | 0.00% | – |
Q4 2021 | $422,000 | +72.2% | 15,273 | +101.2% | 0.00% | – |
Q3 2021 | $245,000 | – | 7,591 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |